Juvena’s platform is applicable across a wide scope of disease indications. Juvena has focused initially on mapping secreted proteins to neuromuscular and skeletal diseases, and are exploring additional areas including cardio-metabolic, pulmonary, and inflammatory. We’re excited to explore partnerships with biopharma companies looking to benefit from the mapping of secreted proteins to therapeutic focus areas.